Clinical trials: Recurrent Anaplastic Astrocytoma
High Grade Glioma, Anaplastic Astrocytoma
DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma
The purpose of this study is to determine if the investigational products, DB107-RRV and DB107-FC, as a combination treatment will shrink high-grade glioma (HGG) in patients with recurrent/progressive, resectable or unresectable…
- Trial name
- NCT06264388
- Testing
- DB107-RRV, DB107-FC
- Where
- United States
- Volunteers
- 33 people
- Sponsor
- Ashish Shah